Veterinary Diagnostics Market Size, Share & COVID-19 Impact Analysis, By Product Type (Instruments and Reagents & Consumables), By Technique (Hematology, Immunodiagnostics, Molecular Diagnostics, Diagnostic Imaging, Clinical Biochemistry, and Others), By Animal Type (Livestock and Companion), By End User (Veterinary Hospitals & Clinics, Veterinary Reference Laboratories, and Others), and Regional Forecast, 2023-2030

The global veterinary diagnostics market size was valued at USD 6.49 billion in 2022 and is projected to grow from USD 7.13 billion in 2023 to USD 14.48 billion by 2030, exhibiting a CAGR of 10.7% during the forecast period.

Veterinary diagnostics are tests carried out by analyzing blood, tissue, urine, or stool to detect disease presence, antibodies, proteins, or general indicators of overall health of various animals. The rising prevalence of veterinary diseases, increasing pet ownership, and growing government support to prevent the spread of zoonotic diseases are projected to fuel the market growth.

• For instance, according to an article published by the National Institutes of Health (NIH) in 2022, the Centers for Disease Control and Prevention (CDC), the Department of the Interior, and the U.S. Department of Agriculture's report mentioned the eight most important zoonosis in the U.S. These constituted the West Nile virus, influenza, coronaviruses, salmonella, plague, rabies, Brucella, and Lyme disease.

Molecular and immunodiagnostic tests are commonly performed for the diagnosis of complex conditions. Such factors are augmenting the growth of the market. Moreover, increasing pet insurance demand and the establishment of new diagnostic laboratories by various industry players across the globe is expected to drive the veterinary diagnostics market growth.

COVID-19 IMPACT

Reopening of Veterinary Clinics during the Second Half of the Pandemic and Rising Pet Adoption Positively Influenced the Market

In 2020, the COVID-19 pandemic had a slight positive influence on the global market. The market witnessed slower growth trends in 2020 due to the vast spread of the virus and lockdown restrictions. In the first half of 2020, veterinary diagnostic services were halted due to travel restrictions and disruptions in the supply chain created by the COVID-19 pandemic. Veterinary services were also limited due to travel restraints and market closures.

However, the market witnessed overall growth during the pandemic as veterinary diagnostics clinics were reopened in the second half of 2020. Furthermore, pet adoption increased, leading to increased veterinary diagnostics visits.

Majority of clinics re-opened in the second half of 2020. Rising visits to these clinics led to a marginal increase in their sales of animal diagnostic products, specifically for companion animals.

• For instance, IDEXX Laboratories, Inc. recorded net sales of USD 2,385.8 million in 2020 from its Companion Animal Group (CAG) segment. The CAG segment sales increased by 21.1% in 2021 compared to 2020 due to increased prices and global demand for companion animal diagnostics.

In 2022, veterinary visits were back to the pre-pandemic level. Such a scenario caused the company’s revenue to stabilize, diverting the market to pre-pandemic growth from 2023 to 2030.

LATEST TRENDS

Request a Free sample to learn more about this report.

Growing Adoption of Point-of-Care in Animal Diagnostics due to its Potential Advantages 

Over the past few years, one of the most prominent trends in the market has been the growing adoption of point-of-care diagnostics for the veterinary process. The point-of-care techniques have improved diagnostics' speed, standardization, and efficacy. These techniques require limited healthcare personnel and can overcome the issue of cross-trained, less-experienced staff at diagnostic services.

Similarly, prominent players' increased focus and initiatives on developing point-of-care diagnostics are expected to drive the growth of the market.

• For instance, in March 2022, Randox Laboratories Ltd. introduced VeraSTAT-V and VeraSTAT in its point-of-care (POC) diagnostics portfolio for equine health.

More companies are launching new and advanced diagnostic tests to expand livestock and companion animal diagnostics globally. The growing technological advancements aid in the high adoption of these services, propelling the market expansion.

DRIVING FACTORS

Increasing Outbreaks of Veterinary Diseases and Positive Government Support to Boost Adoption

Livestock disease outbreaks can be a severe economic burden for countries whose economies depend on animals. Thus, timely diagnosis of the animals becomes necessary. This is anticipated to contribute to the increased demand for veterinary diagnostics.

• As per the European Centre for Disease Prevention and Control article published in 2022, the cases of campylobacteriosis and salmonellosis increased in 2021 compared with 2020. The commonly used tests for these diseases are Enzyme Immunoassay (EIA) or Polymerase Chain Reaction (PCR). Such a rise in the prevalence or incidence of zoonotic diseases is expected to surge the demand for veterinary tests over the forecast timeframe.

Active government support and increased awareness among livestock owners led to an increased demand for animal disease diagnostic tests and kits, which is projected to fuel the market growth.   

Rise in Pet Ownership and Willingness to Spend on Pet Well-being to Propel Growth Prospects

The rising number of pet owners can mainly be attributed to the growing trend of nuclear families and rapid adoption of modern lifestyles. Most households prefer to pet a dog or cat as compared to other animals. The increased disposable incomes and affection toward pet animals are primary factors leading to a surge in pet ownership.

• For instance, according to a Forbes article, in 2023, approximately 66.0% of the U.S. households (86.9 million homes) own a pet.

The rising trend of adopting foster pets is also one of the reasons for increasing the number of pet owners. Along with the increasing pet ownership, rising investment by owners in their pets is another crucial factor propelling the demand for veterinary diagnostics. Such a rise in ownership and increased pet care spending are expected to drive the market growth.

RESTRAINING FACTORS

Shortage of Skilled Veterinary Healthcare Providers to Hinder Industry Growth

One of the substantial hindrances to market growth is the lack of skilled professionals for veterinary diagnostics, especially in major emerging countries. Generally, well trained and qualified professionals are required to operate the highly advanced diagnostic tools. Shortage of skilled and qualified labor plays a significant barrier in the market.

• According to an article published by Frontiers Media S.A. in 2021, the most commonly reported challenges for providing diagnostic laboratory services are insufficient or lack of supplies, equipment, and reagents, costly reagents, inadequate or lack of laboratory staff to perform tests, and inadequate training of laboratory staff.

As a result, veterinary care has remained partly inaccessible for many livestock owners in developed and emerging countries. Many animals remain deprived of veterinary assistance, subsequently impacting the demand for veterinary diagnostics.

SEGMENTATION

By Product Type Analysis

Reagents & Consumables Segment to Dominate due to Increased Frequency of Veterinary Tests 

In terms of product type, the market is segmented into reagents & consumables and instruments. The reagents & consumables segment held a significant market share in 2022. The segment growth is attributed to increased frequency and surge in spending on veterinary tests and services globally. The increased prevalence of animal diseases, growing disposable income, and a strong emphasis on developing advanced reagents and kits by leading players will further propel the market growth.

• For instance, according to an article published by Allianz Global Investors in 2021, veterinary care, including diagnostics, is the second largest area of spending for pet parents, next to food.

The instruments segment is projected to register a moderate CAGR over the forecast period. This is due to the rising number of veterinary hospitals and research institutes or initiatives for companion and livestock animals.

By Technique Analysis

To know how our report can help streamline your business, Speak to Analyst

Immunodiagnostics Segment to Lead Driven by Growing Demand for Advanced Diagnostics

Based on technique, the market is segmented into hematology, immunodiagnostics, molecular diagnostics, diagnostic imaging, clinical biochemistry, and others. Immunodiagnostics segment dominated the global veterinary diagnostics market share in 2022. Immunodiagnostic tests have become a practical and widely used tool for diagnosing animal diseases due to its expanding application areas, such as detecting critical conditions, including arboviral disease.

The clinical biochemistry segment held a significant share in the global market. This is attributable to the growing number of diagnostic tests for the analysis of blood plasma/serum to detect the levels of various substrates, such as hormones, enzymes, proteins, electrolytes, and others, in the body.

The molecular diagnostics segment held a substantial market share in 2022. Significant product launches in this section augment the market growth. In June 2022, the University of Nairobi's Faculty of Veterinary Medicine launched a state-of-the-art Animal Health, Molecular, and Diagnostics laboratory. The lab is a collaborative initiative of the University of Nairobi and Washington State University through the Feed the Future program.

By Animal Type Analysis

Rising Pet Care Expenditure to Drive the Companion Segment

Based on animal type, the market is bifurcated into livestock and companion. The companion segment held a dominant share in the market. Acknowledgment of human and animal companionship and increasing spending on pet care especially in developing countries, are some factors anticipated to boost the segmental growth. The growing launch of various products for companion animal diagnostics is propelling the market expansion.

• In August 2022, PepiPets launched a mobile diagnostic testing service. The service allows clients to receive diagnostic testing at home for their pets.

The livestock segment is expected to grow at a notable rate over the forecast period. This is due to the demand for dairy products and rising emphasis on ensuring livestock animal health. Similarly, the growing attention to preventing food-borne diseases and expanding the poultry sector is propelling the segmental growth prospects.

By End User Analysis

Launch of Veterinary Reference Laboratories by Key Players to Boost the Segment’s Growth

By end user, the market is divided into veterinary reference laboratories, veterinary hospitals & clinics, and others. The veterinary reference laboratories segment held a dominant share of the market. The segment growth is attributed to the growing importance of reference laboratories due to the high standards of diagnostic practices and data reliability. Moreover, the increasing focus on key players in launching reference laboratories with advanced product and service offerings propels the market expansion.

• For instance, in June 2022, IDEXX Laboratories, Inc. launched reference laboratory tests and services. The newly introduced tests were Fecal Dx, FGF-23, and PCR Direct testing. Such initiatives are expected to drive the market growth.

The veterinary hospitals & clinics segment is expected to grow at a lucrative rate over the forecast period. This is due to the rising preference for government veterinary hospitals and clinics in emerging countries such as India.

REGIONAL INSIGHTS

To get more information on the regional analysis of this market, Request a Free sample

In terms of geography, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America generated a revenue of USD 3.54 billion in 2022. Robust adoption of pet animals by the population in the U.S. and Canada, colossal expenditure on pet care, growing employment in the veterinary sector, and favorable reimbursement scenario are major contributors to the region's dominance.

Europe held a substantial share in the global market due to improved healthcare facilities and higher adoption of veterinary testing for the on-time diagnosis of veterinary diseases. Several strategic acquisitions to expand companies' capabilities by providing certain software for easy end-user workflow promote market growth.

• In January 2022, Heska Corporation acquired VetZ GmbH to scale and expand its capabilities and for the well-being of animals in Europe.

Asia Pacific is projected to record a maximum CAGR during 2023-2030. Growing awareness about risks associated with zoonotic diseases and increasing spending on animal care are likely to drive the market growth in emerging countries such as China and India. Furthermore, Latin America and the Middle East & Africa markets are growing due to their huge livestock populations and initiatives focused on creating awareness regarding diagnostic care.

KEY INDUSTRY PLAYERS

Robust Offerings and Strategic Acquisitions by IDEXX Laboratories, Inc., Zoetis Services LLC, and Heska Corporation to Support their Market Dominance

The competitive landscape of the global market is consolidated. IDEXX Laboratories, Inc., dominated the global market share in 2022. The company’s market dominance is due to its robust companion and livestock animal diagnostics product portfolio and market presence. The company introduced the latest instruments, the Catalyst Dx on the chemistry side and the ProCyte Dx for hematology applications.

• In June 2023, IDEXX Laboratories, Inc. launched the IDEXX cystatin B test, the first veterinary diagnostics test for detecting kidney injury in cats and dogs. The company shared plans to launch this test in Europe in 2024.

Zoetis Services LLC and Heska Corporation are prominent players in the veterinary diagnostics sector due to their adoption of strategic acquisitions and partnership initiatives. Other players, such as Virbac, Zomedica Corp., and Shenzhen Mindray Bio-Medical Electronics Co., Ltd., are expanding their market presence to strengthen their industry positions.

LIST OF KEY COMPANIES PROFILED:

• IDEXX Laboratories, Inc. (U.S.)


• Zoetis Services LLC (U.S.)


• Heska Corporation (U.S.)


• Thermo Fisher Scientific Inc. (U.S.)


• Avante Animal Health (U.S.)


• Virbac (France)


• Randox Laboratories Ltd. (U.K.)


• VCA Animal Hospitals (Mars, Incorporated) (U.S.)


• Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China)

KEY INDUSTRY DEVELOPMENTS:

• March 2023: QIAGEN N.V. partnered with Servier to develop a companion diagnostic test for TIBSOVO, an isocitrate dehydrogenase-1 (IDH1) inhibitor. The solution was launched for treating blood cancer Acute Myeloid Leukemia (AML). Under this collaboration, QIAGEN would develop and validate a real-time in vitro PCR test that can be used to detect IDH1 gene mutations in AML patients in whole blood and bone marrow aspirates.


• February 2023: Heska Corporation announced the availability of VolitionRx Limited’s Nu. Q Vet Cancer Test for pre-order through its point-of-care segment.


• February 2023: Virbac opened its research and development center dedicated to warm water aquaculture in Vietnam. It also serves as a diagnostic center.


• October 2022: Avante Animal Health and Vetiqure AB, a subsidiary of ChemoTech, signed a letter of intent to get into a distribution agreement and install approximately six vetIQure systems at various university hospitals and leading clinics.


• January 2022: IDEXX Laboratories, Inc. extended the reference laboratory menu by including innovative genomic diagnostics. The initiative helped expand the company's oncology offerings.

REPORT COVERAGE

An Infographic Representation of Veterinary Diagnostics Market

View Full Infographic

To get information on various segments, share your queries with us

The global veterinary diagnostics market research report provides a detailed market analysis. It highlights key segments such as product type, technique, animal type, end user, and geography. Moreover, the report highlights insights into market dynamics, the prevalence of key veterinary diseases, pet ownership statistics, pet insurance scenarios, industry developments, industry trends, technological advancements, prominent players, and the COVID-19 impact on the market. Similarly, the report provides various dynamics that contribute to the overall market development.

Report Scope & Segmentation